← Back to Clinical Trials
Recruiting NCT05185141

NCT05185141 Respiratory Variation of Carotid Doppler Peak Velocity (CDPV) for Non-invasive Prediction of Fluid Responsiveness

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05185141
Status Recruiting
Phase
Sponsor Johannes Gutenberg University Mainz
Condition Hemodynamic Instability
Study Type OBSERVATIONAL
Enrollment 84 participants
Start Date 2022-01-11
Primary Completion 2026-07

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 80 Years
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 84 participants in total. It began in 2022-01-11 with a primary completion date of 2026-07.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The purpose of this study is to assess respiratory variation of carotid doppler peak velocity (∆CDPV) for prediction of fluid responsiveness during major abdominal surgery.

Eligibility Criteria

Inclusion Criteria: * Age 18-80 years * written informed consent * scheduled major abdominal surgery Exclusion Criteria: * Age \<18 or \>80 years * pregnancy * SIRS or sepsis * any kind of cardiac arrhythmia * known valve disease * known heart failure * any kind of known carotid stenosis * carotid doppler peak velocity \>182 cm/s before baseline measurement (expected stenosis) * missing indication for invasive arterial blood pressure monitoring (IBP) not related to the study * peripheral artery disease (PAD) * BMI \> 35 kg/m2 * intraabdominal hypertension * ASA-PSC of 4 * severe lung disease (e.g. COPD grade 3, fibrosis) * esophageal disease of any kind * participation in another clinical study

Contact & Investigator

Central Contact

Johannes M Wirkus, M.D.

✉ johannes.wirkus@unimedizin-mainz.de

📞 +49 6131 17- 7175

Principal Investigator

Gunther J Pestel, M.D., Ph.D.

STUDY CHAIR

Johannes Gutenberg University Medical Center, Dpt. of Anesthesiology

Frequently Asked Questions

Who can join the NCT05185141 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Hemodynamic Instability. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05185141 currently recruiting?

Yes, NCT05185141 is actively recruiting participants. Contact the research team at johannes.wirkus@unimedizin-mainz.de for enrollment information.

Where is the NCT05185141 trial being conducted?

This trial is being conducted at Mainz, Germany.

Who is sponsoring the NCT05185141 clinical trial?

NCT05185141 is sponsored by Johannes Gutenberg University Mainz. The principal investigator is Gunther J Pestel, M.D., Ph.D. at Johannes Gutenberg University Medical Center, Dpt. of Anesthesiology. The trial plans to enroll 84 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology